I have been doing a bit of reading on Cyclopharm and find the company very interesting .... what is holding me back from buying at the moment is trying to understanding the competitive landscape in the US. Does anyone have any insights in this area and in particular if non radioactive hyperpolarized 129 Xenon gas represents a competitive threat ? One company seems about to complete an FDA phase III non inferiority study against 133-Xenon scintigraphy with this, which is exactly the same comparator as CYCs trial ?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.005(0.46%) |
Mkt cap ! $119.4M | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.09 | $1.02 | $9.779K | 9.078K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3106 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 12250 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| CYC (ASX) Chart |